Stine Trolle

Global Health Pharmacist

[Stine Trolle @StineTrolle]

Proud to have been part of the new #ATMF2018 analyzing the 20 largest pharmaceutical companies contribution to improved access. Published today!

[Access to Medicine Foundation @AtMIndex]

Online Now: New Access to Medicine Index for stimulating #pharma companies to do more for #access2meds. #ATMI2018 https://t.co/irJDPxkyyB #access2meds #pharma Funded by @DFID_UK @gatesfoundation @DutchMFA

[Clarke Cole @clarkebcole]

Pleased to share the latest commentary on measuring and incentivising #pharma contributions to #health R&D @StineTrolle @dannyjedwards @AtMIndex https://t.co/ORqxhKS59J

[Stine Trolle @StineTrolle]

Proud to participate in the #AIDS2018 conference in Amsterdam. #chasethevirusnotthepeople

[Access to Medicine Foundation @AtMIndex]

There is an emerging crisis in the global anti-infectives market - supply is patchy, leading to regional and global shortages, #disease outbreaks and an increased risk of #AMR. Read more in our new white paper published today: https://t.co/qxf1ccWJ6w

[Access to Medicine Foundation @AtMIndex]

Antibiotic supply is patchy, complex and at risk of collapsing. Today, we publish a new white paper that identifies how #pharma co.s are already strengthening #antibiotic supply chains: https://t.co/o6jN7Bdjhl

[Access to Medicine Foundation @AtMIndex]

How can companies accelerate R&D of #meds & #vaccines for #LMICs? We have worked with @BIOVentures to develop a framework that can guide #pharma co.s in making decisions about sharing their #intellectualproperty with #globalhealth researchers: https://t.co/jdCD733TEk

[Access to Medicine Foundation @AtMIndex]

“For me, the hard work pays off every time we hear real evidence of how it makes change." – Danny Edwards, Research Programme Manager, #ATMIndex

Join @dannyjedwards and our team make change in the #pharma industry

https://t.co/HD2EsFPyx7

[Access to Medicine Foundation @AtMIndex]

What's in the pipeline for #prioritypathogens? #AMRBenchmark mapped the pipelines of #pharma co.s active in antimicrobial R&D - we found 18 #vaccines out of 175 R&D projects targeting the toughest pathogens.

https://t.co/RC23z8TF1y

#AMR @sanofi @PAHOemergencies @Entasistx

[Tedros Adhanom Ghebreyesus @DrTedros]

Today is #WorldCancerDay. #Cancer is responsible for 1 in 6 deaths worldwide, but up to 50% of all cancers are preventable. Here are 10 ways we can all reduce our risk and prevent cancer - let’s #BeatNCDs.

[Stine Trolle @StineTrolle]

Pleased to be a part of the discussion on the future #R&D model at the meeting Open Science for Health: Shaping the New Framework Programme #Open4Health #access2meds #euparliament #H2020 #FP9

[Access to Medicine Foundation @AtMIndex]

.@BillGates at #WEF18: When the Access to Medicine Index came along, pharma companies could get credit for actually working on infectious diseases.

https://t.co/WDqnj74C0d

#ATMIndex2018 #AMRBenchmark @JayasreeKIyer @joelletanguy @BeckyQuick @gatesfoundation @minvws @DFID_UK

[Access to Medicine Foundation @AtMIndex]

"More international calls for progress and clear priorities is what leads to action taking by #pharma companies"
@JayasreeKIyer at #WEF18https://goo.gl/dJocFK

@joelletanguy @BeckyQuick @BillGates @melindagates @gatesfoundation @minvws @MarcelvanRaaij @DFID_UK @CMO_England

[Access to Medicine Foundation @AtMIndex]

"We have seen growth in investors signing onto the principles of #access2medicine, and interest in the industry's role"
@JayasreeKIyer at #WEF18 https://t.co/HHNRTLPL97

@joelletanguy @BeckyQuick @BillGates @melindagates @gatesfoundation @minvws @MarcelvanRaaij @DFID_UK

[Access to Medicine Foundation @AtMIndex]

Watch live at 1pm @JayasreeKIyer, @BillGates and others discuss entering a new era of global health. https://t.co/8cxEoC2cS8
@BillGates @melindagates @gatesfoundation @trevormundel
@minvws @DutchMFA @markrutte @MarcelvanRaaij @LambertGrijns
@DFID_UK @PennyMordaunt @CMO_England

[Access to Medicine Foundation @AtMIndex]

Now online: The first Antimicrobial Resistance Benchmark. The #AMRBenchmark is the 1st independent report to systematically evaluate how #pharma co.s are tacking #AMR: https://t.co/gVe3VlHc44

[Access to Medicine Foundation @AtMIndex]

Two hours to go: watch the press conference about the first #AMRBenchmark at the @WEF – it starts at 1pm GMT/ 2pm CET/ 8am EST/ 6:30pm IST/10pm JST. Find out which #pharma companies do more to curb #AMR https://t.co/M8nhL930ja

[Access to Medicine Foundation @AtMIndex]

Watch the live launch of our #AMRBenchmark on Tues, 23 Jan! Our @JayasreeKIyer will present the #AMR Benchmark results & findings for the first time in a livestreamed press conference at #WEF2018 : https://t.co/DQEmE5NbNs @wef

[Access to Medicine Foundation @AtMIndex]

We are now researching access to #cancer care. Learn why & how it has been brought into the #AtMIndex2018 methodology: https://t.co/FGKPSDmPth

[Stine Trolle @StineTrolle]

How can we measure actions by pharma companies to improve access to #cancer care in LMICs? I am excited to share an article by my team and I about how the @AtMIndex will be incorporating cancer into the 2018 Access to Medicine Index. #access2med https://t.co/FFargVBrGu

[Access to Medicine Foundation @AtMIndex]

How is the Access to Medicine Foundation raising the bar for Index making? https://t.co/wiD4uGKTtb